These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 23345608)

  • 1. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
    Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
    Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
    Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
    BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
    Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
    Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.
    Yegnasubramanian S; Haffner MC; Zhang Y; Gurel B; Cornish TC; Wu Z; Irizarry RA; Morgan J; Hicks J; DeWeese TL; Isaacs WB; Bova GS; De Marzo AM; Nelson WG
    Cancer Res; 2008 Nov; 68(21):8954-67. PubMed ID: 18974140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIC1 modulates prostate cancer progression by epigenetic modification.
    Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
    Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation.
    Rauluseviciute I; Drabløs F; Rye MB
    BMC Med Genomics; 2020 Jan; 13(1):6. PubMed ID: 31914996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
    Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
    Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer.
    Hlady RA; Zhou D; Puszyk W; Roberts LR; Liu C; Robertson KD
    Epigenetics; 2017 Mar; 12(3):215-225. PubMed ID: 28059585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
    Yegnasubramanian S; De Marzo AM; Nelson WG
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
    Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
    Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of the ITGB4 gene in prostate cancer.
    Wilkinson EJ; Woodworth AM; Parker M; Phillips JL; Malley RC; Dickinson JL; Holloway AF
    Exp Cell Res; 2020 Jul; 392(2):112055. PubMed ID: 32376286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
    Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
    Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation in prostate cancer.
    Park JY
    Cancer Control; 2010 Oct; 17(4):245-55. PubMed ID: 20861812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation changes in prostate cancer.
    Goering W; Kloth M; Schulz WA
    Methods Mol Biol; 2012; 863():47-66. PubMed ID: 22359287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.